Xiaohua Xing

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Inflammatory Response

Gas Chromatography

Top Venues

EMBO molecular medicine

Nature communications

Cancer management and research

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Liman Qiu, Hongbing Ji, Kai Wang, Wenhan Liu, Qizhen Huang, Xinting Pan, Honghao Ye, Zhenli Li, Geng Chen, Xiaohua Xing, Xiuqing Dong, Ruijing Tang, Haipo Xu, Jingfeng Liu, Zhixiong Cai, Xiao-Long Liu
TLR3 activation enhances abscopal effect of radiotherapy in HCC by promoting tumor ferroptosis. EMBO molecular medicine (2024)
Liman Qiu, Hongbing Ji, Kai Wang, Wenhan Liu, Qizhen Huang, Xinting Pan, Honghao Ye, Zhenli Li, Geng Chen, Xiaohua Xing, Xiuqing Dong, Ruijing Tang, Haipo Xu, Jingfeng Liu, Zhixiong Cai, Xiao-Long Liu
TLR3 activation enhances abscopal effect of radiotherapy in HCC by promoting tumor ferroptosis. EMBO molecular medicine 16 (5) (2024)
Liman Qiu, Hongbing Ji, Kai Wang, Wenhan Liu, Qizhen Huang, Xinting Pan, Honghao Ye, Zhenli Li, Geng Chen, Xiaohua Xing, Xiuqing Dong, Ruijing Tang, Haipo Xu, Jingfeng Liu, Zhixiong Cai, Xiao-Long Liu
TLR3 activation enhances abscopal effect of radiotherapy in HCC by promoting tumor ferroptosis. EMBO molecular medicine 16 (5) (2024)
Liman Qiu, Hongbing Ji, Kai Wang, Wenhan Liu, Qizhen Huang, Xinting Pan, Honghao Ye, Zhenli Li, Geng Chen, Xiaohua Xing, Xiuqing Dong, Ruijing Tang, Haipo Xu, Jingfeng Liu, Zhixiong Cai, Xiao-Long Liu
TLR3 activation enhances abscopal effect of radiotherapy in HCC by promoting tumor ferroptosis. EMBO molecular medicine 16 (5) (2024)
Liman Qiu, Hongbing Ji, Kai Wang, Wenhan Liu, Qizhen Huang, Xinting Pan, Honghao Ye, Zhenli Li, Geng Chen, Xiaohua Xing, Xiuqing Dong, Ruijing Tang, Haipo Xu, Jingfeng Liu, Zhixiong Cai, Xiao-Long Liu
TLR3 activation enhances abscopal effect of radiotherapy in HCC by promoting tumor ferroptosis. EMBO molecular medicine 16 (5) (2024)
Liman Qiu, Hongbing Ji, Kai Wang, Wenhan Liu, Qizhen Huang, Xinting Pan, Honghao Ye, Zhenli Li, Geng Chen, Xiaohua Xing, Xiuqing Dong, Ruijing Tang, Haipo Xu, Jingfeng Liu, Zhixiong Cai, Xiao-Long Liu
TLR3 activation enhances abscopal effect of radiotherapy in HCC by promoting tumor ferroptosis. EMBO molecular medicine 16 (5) (2024)
Qiuyu Zhuang, Zhiguo Dai, Xuechun Xu, Shaoyi Bai, Yindan Zhang, Youshi Zheng, Xiaohua Xing, En Hu, Yingchao Wang, Wuhua Guo, Bixing Zhao, Yongyi Zeng, Xiao-Long Liu
RNA methyltransferase FTSJ3 regulates the type I interferon pathway to promote hepatocellular carcinoma immune evasion. Cancer research (2023)
Xiaohua Xing, Linsheng Cai, Jiahe Ouyang, Fei Wang, Zongman Li, Mingxin Liu, Yingchao Wang, Yang Zhou, En Hu, Changli Huang, Liming Wu, Jingfeng Liu, Xiao-Long Liu
Proteomics-driven noninvasive screening of circulating serum protein panels for the early diagnosis of hepatocellular carcinoma. Nature communications 14 (1) (2023)
Xiaohua Xing, Linsheng Cai, Jiahe Ouyang, Fei Wang, Zongman Li, Mingxin Liu, Yingchao Wang, Yang Zhou, En Hu, Changli Huang, Liming Wu, Jingfeng Liu, Xiao-Long Liu
Proteomics-driven noninvasive screening of circulating serum protein panels for the early diagnosis of hepatocellular carcinoma. Nature communications 14 (1) (2023)
Xiaohua Xing, Linsheng Cai, Jiahe Ouyang, Fei Wang, Zongman Li, Mingxin Liu, Yingchao Wang, Yang Zhou, En Hu, Changli Huang, Liming Wu, Jingfeng Liu, Xiao-Long Liu
Proteomics-driven noninvasive screening of circulating serum protein panels for the early diagnosis of hepatocellular carcinoma. Nature communications 14 (1) (2023)
Xiaohua Xing, Linsheng Cai, Jiahe Ouyang, Fei Wang, Zongman Li, Mingxin Liu, Yingchao Wang, Yang Zhou, En Hu, Changli Huang, Liming Wu, Jingfeng Liu, Xiao-Long Liu
Proteomics-driven noninvasive screening of circulating serum protein panels for the early diagnosis of hepatocellular carcinoma. Nature communications 14 (1) (2023)
Xincong Lin, Yao Huang, Ying Sun, Xionghong Tan, Jiahe Ouyang, Bixing Zhao, Yingchao Wang, Xiaohua Xing, Jingfeng Liu
4E-BP1Thr46 Phosphorylation Association with Poor Prognosis in Quantitative Phosphoproteomics of Portal Vein Tumor Thrombus Revealed that 4E-BP1Thr46 Phosphorylation is Associated with Poor Prognosis in HCC. Cancer management and research 12 (2020)